Fructose and Galactose Metabolism

Fructose Metabolism

Overview
  • Fructose is primarily metabolized in the liver, small intestine, and kidneys.
Key Enzymes and Reactions
  • Aldolase B: This enzyme has a low affinity for fructose 1-phosphate, leading to:
    • Accumulation of Fructose 1-Phosphate in the liver, which can cause metabolic issues.
Disorders Associated with Fructose Metabolism
  1. Essential Fructosuria: A genetic condition characterized by the inability to metabolize fructose, resulting in its accumulation in the urine.
  2. Hereditary Fructose Intolerance: A more severe genetic disorder leading to adverse effects upon ingestion of fructose due to toxic accumulation.

The Polyol Pathway

Functionality
  • The polyol pathway allows for the conversion of glucose into sorbitol, which is crucial in certain tissues, particularly in:
    • Seminal vesicles: Spermatozoa utilize fructose as an energy source.
Clinical Implications
  • In diabetic patients, an accumulation of sorbitol occurs due to high glucose levels, leading to several complications:
    • Diabetic Cataract: Increased glucose concentration in the lens results in elevated aldose reductase activity,
    • This causes sorbitol accumulation, leading to:
      • Increased osmolarity
      • Structural changes in lens proteins
    • Peripheral Neuropathy: Affecting both muscles and nerves due to similar mechanisms of sorbitol accumulation.

Galactose Metabolism

Overview
  • Galactose undergoes a series of enzymatic reactions primarily in the liver.
Key Enzymatic Pathways
  • Galactokinase: Converts galactose into galactose-1-phosphate,
  • Galactose-1-Phosphate Uridylyltransferase: Converts galactose-1-phosphate to glucose-1-phosphate,
  • Epimerase: Converts UDP-galactose into UDP-glucose.
  • Final products lead to the entry of glucose into glycolysis in various tissues.
Clinical Correlations
  1. Nonclassical Galactosemia: A milder form of galactosemia not involving severe symptoms.
  2. Classical Galactosemia: Involves severe deficiency of Galactose-1-Phosphate Uridylyltransferase leading to clinical manifestations such as:
    • Hepatomegaly
    • Jaundice
    • Cataracts
    • Mental retardation
    • Potentially fatal if untreated.

Lens Metabolism

  • Increased glucose concentration in the ocular lens leads to:
    • Enhanced aldose reductase activity,
    • Resulting in sorbitol accumulation which augments osmolarity, causing structural protein changes culminating in the development of diabetic cataracts.

Clinical Correlations in Newborns

  • Newborns exhibiting:
    • Failure to Thrive
    • Vomiting and Diarrhea after milk ingestion may have:
    • Galactosemia (caused by a deficiency in Galactose-1-Phosphate Uridylyltransferase).
    • This genetic condition has an autosomal recessive inheritance pattern with an incidence of approximately 1 in 60,000 births.
    • Associated symptoms may include:
    • Hepatomegaly
    • Jaundice
    • Cataracts
    • Mental retardation
    • Risk of death if undiagnosed or untreated.
Management Strategy
  • Early diagnosis is crucial for managing galactosemia, including:
    • Dietary Elimination of galactose from the diet, often replaced with artificial milk derived from soybean hydrolysate.

Summary of Fructose and Galactose Metabolism

  • Both fructose and galactose are converted into intermediates of glycolysis.
  • Genetic abnormalities can lead to the accumulation of toxic intermediates, resulting in tissue damage.
  • Sorbitol accumulation is a significant concern in patients with diabetes, leading to complications such as diabetic cataracts.